Orthofix Medical Inc.
General ticker "OFIX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $529.0M (TTM average)
Orthofix Medical Inc. does not follow the US Stock Market performance with the rate: -27.2%.
Estimated limits based on current volatility of 1.8%: low 9.26$, high 9.61$
Factors to consider:
- Total employees count: 1605 (-0.7%) as of 2025
- US accounted for 80.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Regulatory and compliance, Supply chain disruptions, Product liability claims, Product development failure
- Current price 21.9% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [12.01$, 22.69$]
- 2026-12-31 to 2027-12-31 estimated range: [10.94$, 21.18$]
Financial Metrics affecting the OFIX estimates:
- Negative: with PPE of -6.5 at the end of fiscal year the price was high
- Positive: -13.52 < Operating profit margin, % of -7.69
- Positive: 4.90 < Operating cash flow per share per price, % of 5.48
- Positive: Interest expense per share per price, % of 2.87 <= 4.56
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: 49.86 < Shareholder equity ratio, % of 52.91 <= 58.56
Short-term OFIX quotes
Long-term OFIX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $746.64MM | $799.49MM | $822.31MM |
| Operating Expenses | $885.75MM | $884.11MM | $890.78MM |
| Operating Income | $-139.11MM | $-84.62MM | $-68.47MM |
| Non-Operating Income | $-9.57MM | $-39.26MM | $-22.34MM |
| Interest Expense | $8.63MM | $29.63MM | $17.49MM |
| R&D Expense | $80.23MM | $73.64MM | $65.85MM |
| Income(Loss) | $-148.68MM | $-123.88MM | $-90.81MM |
| Taxes | $2.72MM | $2.12MM | $1.38MM |
| Net Income(Loss)* | $-151.40MM | $-126.00MM | $-92.19MM |
| Stockholders Equity | $598.73MM | $503.12MM | $450.04MM |
| Inventory | $222.17MM | $189.45MM | $34.17MM |
| Assets | $925.32MM | $893.29MM | $850.65MM |
| Operating Cash Flow | $-45.75MM | $25.79MM | $33.35MM |
| Capital expenditure | $62.05MM | $34.88MM | $34.63MM |
| Investing Cash Flow | $-33.13MM | $-27.58MM | $-34.60MM |
| Financing Cash Flow | $65.32MM | $50.71MM | $-0.79MM |
| Earnings Per Share** | $-4.12 | $-3.30 | $-2.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.